AFFYMETRIX INC | 2,80 Euro | -0,032 -1,13 % | |
| WKN: 901198 ISIN: US00826T1088 Ticker-Symbol: AFF | Frankfurt | 23.05.13 | 15:31 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 20.05. | Affymetrix Names Gavin Wood Chief Financial Officer | - | Euroinvestor | |
| 20.05. | Affymetrix CFO Barabe to retire in June | - | Yahoo-USA | |
| 20.05. | Affymetrix Names Gavin Wood EVP & CFO | 63 | AFX News | |
| WASHINGTON (dpa-AFX) - Affymetrix Inc. (AFFX) announced the appointment of
Gavin Wood as Executive Vice President and Chief Financial Officer. Tim Barabe,
the current CFO, is expected to... Mehr lesen zu: Affymetrix Names Gavin Wood EVP & CFO | ||||
| 20.05. | Affymetrix Names Gavin Wood CFO | - | Benzinga.com | |
| 17.05. | Shares of Affymetrix Rank the Lowest in Terms of Price to Book Ratio in the Life Sciences Tools & Services Industry | 1 | SmarTrend | |
| 10.05. | AFFYMETRIX INC - 8-K, Current Report | 3 | SEC Filings | |
| 06.05. | Relatively Low Price to Book Ratio Detected in Shares of Affymetrix in the Life Sciences Tools & Services Industry | 6 | SmarTrend | |
| 02.05. | Affymetrix Reports Disappointing 1Q | 4 | Zacks | |
| 01.05. | Charting Affymetrix's Latest Earnings Release | 4 | Motley Fool | |
| 01.05. | Affymetrix Management Discusses Q1 2013 Results - Earnings Call Transcript | 4 | Seeking Alpha | |
| 22.04. | Possible Bearish Inside Day Candle Pattern Detected for Affymetrix | 6 | SmarTrend | |
| 22.04. | Investors look to Lighten Up on Shares of Affymetrix, Shares Down 8.4% | 8 | SmarTrend | |
| 15.04. | Affymetrix Down to Underperform | 18 | Zacks | |
| 10.04. | Affymetrix to Disappoint in 1Q | 15 | Zacks | |
| 10.04. | Affymetrix (AFFX), BioDiscovery Announce Availability of OncoScan FFPE Express 2.0 Service | 1 | StreetInsider.com | |
| 09.04. | Affymetrix's Self-Diagnosis Sends Shares Lower | 6 | Motley Fool | |
| 09.04. | Affymetrix Sees Q1 Prelim. Revenue Of About $78 Mln | 46 | AFX News | |
| WASHINGTON (dpa-AFX) - Affymetrix, Inc. (AFFX), based on preliminary
financial data, expects total revenue of around $78 million for the first
quarter of 2013, including revenue of nearly... Mehr lesen zu: Affymetrix Sees Q1 Prelim. Revenue Of About $78 Mln | ||||
| 08.04. | Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck | 24 | PR Newswire | |
| REDWOOD CITY, Calif. and SANTA CLARA, Calif., April 8, 2013 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, and Affymetrix®, Inc. (NASDAQ:... Mehr lesen zu: Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck | ||||
| 31.03. | Relatively Low Price to Cash Flow Detected in Shares of Affymetrix in the Life Sciences Tools & Services Industry | 6 | SmarTrend | |
| 28.03. | Affymetrix Inks Deal with UK Biobank | 4 | Zacks | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MORPHOSYS | 34,015 | -3,65 % | MorphoSys AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| QIAGEN | 14,45 | -1,47 % | Qiagen und SYGNIS Pharma schließen Lizenzvertrag |
| MEDIGENE | 0,88 | -2,22 % | Medigene-Aktie feiert Studienergebnisse mit EndoTAG |
| AMGEN | 79,91 | -3,46 % | Amgen Announces Voting Results of Annual Meeting of Stockholders |
| AGENNIX | 0,101 | -12,17 % | Agennix AG gibt Liquidation bekannt |
